GeneBioTech Co. Ltd (086060) — Strategic Asset Allocation Index
GeneBioTech Co. Ltd (086060) has a Strategic Asset Allocation Index of 27.9% as of March 2025. Strategic assets (PP&E of ₩14.41 Billion plus long-term investments of ₩-) total ₩14.41 Billion, measured against net assets of ₩51.73 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See GeneBioTech Co. Ltd net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
GeneBioTech Co. Ltd Strategic Asset Allocation Index (2009–2024)
This chart shows how GeneBioTech Co. Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2009 to 2024. As of March 2025, the index stands at 27.9%, representing strategic assets of ₩14.41 Billion against net assets of ₩51.73 Billion KRW. For live market cap and overall valuation, see GeneBioTech Co. Ltd (086060) market capitalisation.
Annual Strategic Asset Allocation Index for GeneBioTech Co. Ltd (2009–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for GeneBioTech Co. Ltd from 2009 to 2024, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 086060 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 27.3% | ₩13.92 Billion | ₩13.92 Billion | ₩- | ₩50.97 Billion | ▼ -2.0 pp |
| 2023 | 29.3% | ₩14.16 Billion | ₩14.16 Billion | ₩- | ₩48.30 Billion | ▼ -2.6 pp |
| 2022 | 32.0% | ₩14.61 Billion | ₩14.61 Billion | ₩- | ₩45.73 Billion | ▼ -1.9 pp |
| 2021 | 33.9% | ₩14.90 Billion | ₩14.90 Billion | ₩- | ₩43.95 Billion | ▲ +5.2 pp |
| 2020 | 28.7% | ₩12.91 Billion | ₩12.91 Billion | ₩- | ₩45.04 Billion | ▼ -18.0 pp |
| 2019 | 46.6% | ₩21.88 Billion | ₩18.77 Billion | ₩3.11 Billion | ₩46.93 Billion | ▼ -0.4 pp |
| 2018 | 47.1% | ₩22.57 Billion | ₩17.93 Billion | ₩4.64 Billion | ₩47.96 Billion | ▼ -18.8 pp |
| 2017 | 65.8% | ₩26.66 Billion | ₩18.35 Billion | ₩8.31 Billion | ₩40.49 Billion | ▼ -9.9 pp |
| 2016 | 75.7% | ₩29.56 Billion | ₩20.10 Billion | ₩9.46 Billion | ₩39.02 Billion | ▲ +4.2 pp |
| 2015 | 71.5% | ₩20.62 Billion | ₩20.03 Billion | ₩591.75 Million | ₩28.84 Billion | ▼ -16.5 pp |
| 2014 | 88.0% | ₩20.61 Billion | ₩19.82 Billion | ₩787.96 Million | ₩23.42 Billion | ▼ 0.0 pp |
| 2013 | 88.0% | ₩20.33 Billion | ₩20.33 Billion | ₩- | ₩23.10 Billion | ▼ -12.6 pp |
| 2012 | 100.7% | ₩21.42 Billion | ₩21.42 Billion | ₩- | ₩21.27 Billion | ▼ -2.7 pp |
| 2011 | 103.4% | ₩20.13 Billion | ₩20.13 Billion | ₩- | ₩19.48 Billion | ▲ +27.9 pp |
| 2010 | 75.5% | ₩13.88 Billion | ₩13.88 Billion | ₩- | ₩18.38 Billion | ▼ -5.0 pp |
| 2009 | 80.5% | ₩14.55 Billion | ₩14.55 Billion | ₩- | ₩18.08 Billion | — |